SEC Form 4 · accession 0001246360-17-001558
NxStage Medical, Inc. · NXTM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert S. Brown
Officer — President, NxStage Kidney Care
Period of report
Apr 3, 2017
Accepted (ET)
Apr 4, 2017 · 5:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001333170
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 3, 2017 | M | 11,917 | $15.58 | A | 28,003 | D | |
| Common Stock | Apr 3, 2017 | S | 14,397 | $26.60 | D | 13,606 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $15.58 | Apr 3, 2017 | M | 11,917 | D | Apr 9, 2016 | Mar 8, 2026 | Common Stock | 11,917 | 59,592 | D |
Explanation of responses
- F1This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2016.